Published trade mark details for 2521461
This information was published on 2025-02-27T09:05:33 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2521461 (IR 1838822) |
| (220) |
14 Aug 2024
|
| (300) |
US, 12 Jun 2024, 98597164
|
| (500) |
The mark consists of the word ORBITAL over the word THERAPEUTICS both to the right of a stylized circle with a swirling line around it, the circle and the line both composed of circles of varying sizes.
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; therapeutic and preventative vaccines; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of diseases and disorders; RNA-based therapeutics; therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders. Class 42 Research and development in the biotechnology field; consulting services in the fields of biotechnology and genetic science; development of new technology for others in the fields of genomics and biotechnology; providing laboratory research services in the field of gene expression or RNA-based therapeutics; testing, inspection, research, or development of chemical and biotechnology preparations; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids. |
| (540) |
|
| (550) | Figurative |
| (730) |
Orbital Therapeutics, Inc.
|
Find out more about publications on the About page.